What is Pacific Link Consulting?
Headquartered in San Diego with a strategic footprint spanning Tokyo and London, Pacific Link Consulting operates as a premier advisory firm dedicated to the pharmaceutical and biotech sectors. The company leverages over five decades of collective expertise to provide comprehensive support in regulatory strategy, clinical trial management, and end-to-end product development. By integrating former industry executives into its core team, the firm offers a unique value proposition that bridges the gap between rigorous scientific requirements and commercial viability. Their operational model is designed to mitigate risk for clients in the US, Europe, Canada, and Japan, ensuring that complex drug development programs adhere to stringent international standards while maintaining efficient timelines.
How much funding has Pacific Link Consulting raised?
Pacific Link Consulting has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Pacific Link Consulting
PPP
Public-Private Partnership
What's next for Pacific Link Consulting?
The recent capital injection serves as a catalyst for the firm's next phase of growth, likely focusing on the expansion of its clinical trial management infrastructure and the deepening of its regulatory intelligence capabilities. As the life sciences industry faces increasing scrutiny and evolving compliance requirements, Pacific Link Consulting is poised to capitalize on the rising demand for expert-led advisory services. The firm is expected to utilize this financing to scale its global operations, potentially enhancing its presence in key biotech hubs and investing in proprietary methodologies that streamline the path from clinical development to market authorization. This strategic move signals a transition toward broader market influence and a strengthened commitment to supporting the next generation of therapeutic breakthroughs.
See full Pacific Link Consulting company page
